Old Web
English
Sign In
Acemap
>
authorDetail
>
Xiaochuan Liu
Xiaochuan Liu
Hefei Institutes of Physical Science
Kinase
Biochemistry
Chemistry
Signal transduction
Axitinib
3
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Axitinib overcomes multiple imatinib resistant cKIT mutations including the gatekeeper mutation T670I in gastrointestinal stromal tumors
2019
Therapeutic Advances in Medical Oncology
Feiyang Liu
Fengming Zou
Cheng Chen
Kailin Yu
Xiaochuan Liu
Shuang Qi
Jiaxin Wu
Chen Hu
Zhenquan Hu
Juan Liu
Xuesong Liu
Li Wang
Juan Ge
Wenchao Wang
Tao Ren
Mingfeng Bai
Yujiao Cai
Xudong Xiao
Feng Qian
Jun Tang
Qingsong Liu
Jing Liu
Show All
Source
Cite
Save
Citations (0)
Discovery of (E)-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thio)propanamide (CHMFL-ABL-121) as a highly potent ABL kinase inhibitor capable of overcoming a variety of ABL mutants including T315I for chronic myeloid leukemia
2018
European Journal of Medicinal Chemistry
Xuesong Liu
Beilei Wang
Cheng Chen
Zongru Jiang
Chen Hu
Hong Wu
Yicong Zhang
Xiaochuan Liu
Wenliang Wang
Junjie Wang
Zhenquan Hu
Aoli Wang
Tao Huang
Qingwang Liu
Wei Wang
Li Wang
Wenchao Wang
Tao Ren
Lili Li
Ruixiang Xia
Jian Ge
Qingsong Liu
Jing Liu
Show All
Source
Cite
Save
Citations (4)
Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor
2018
European Journal of Medicinal Chemistry
Xiaofei Liang
Feng Li
Cheng Chen
Zongru Jiang
Aoli Wang
Xiaochuan Liu
Juan Ge
Zhenquan Hu
Kailin Yu
Wenliang Wang
Fengming Zou
Qingwang Liu
Beilei Wang
Li Wang
Shanchun Zhang
Yuxin Wang
Qingsong Liu
Jing Liu
Show All
Source
Cite
Save
Citations (5)
1